Skip to main content

Table 1 Patient information

From: IL-35 subunit EBI3 alleviates bleomycin-induced pulmonary fibrosis via suppressing DNA enrichment of STAT3

Sample name Disease Gender Age FEVI%pred FVC%pred Drug for antifibrotics
PBMC#1 Pulmonary fibrosis Female 47 55.8 84.2 No
PBMC#2 Pulmonary fibrosis Male 45 77.2 83 Esbriet
PBMC#3 Pulmonary fibrosis Male 51 63.9 80.6 No
PBMC#4 Pulmonary fibrosis Female 30 81.9 75.6 Esbriet
PBMC#5 Pulmonary fibrosis Male 42 76.3 80.9 No
PBMC#6 Pulmonary fibrosis Female 33 81.3 71.2 No
PBMC#7 Pulmonary fibrosis Female 38 77.8 85.7 No
PBMC#8 Pulmonary fibrosis Female 54 57.1 76.5 No
PBMC#9 Pulmonary fibrosis Male 55 67.6 73.6 No
PBMC#10 Pulmonary fibrosis Male 38 88 72.2 Esbriet
PBMC#11 Pulmonary fibrosis Male 20 69.5 71.8 No
PBMC#12 Pulmonary fibrosis Female 49 62.2 75.4 No
PBMC#13 Pulmonary fibrosis Female 29 62.2 70.7 No
PBMC#14 Pulmonary fibrosis Male 58 79.9 85.6 No
PBMC#15 Pulmonary fibrosis Female 42 74 81.6 No
PBMC#16 Pulmonary fibrosis Male 48 76.7 80.6 No
PBMC#17 Pulmonary fibrosis Male 35 60.1 80.2 No
PBMC#18 Healthy control Female 51 95.4 96.1 No
PBMC#19 Healthy control Male 29 94.6 95.4 No
PBMC#20 Healthy control Female 34 96.4 96.9 No
PBMC#21 Healthy control Female 51 96.1 96.6 No
PBMC#22 Healthy control Male 36 88.9 90.2 No
PBMC#23 Healthy control Male 41 97.2 97.7 No
PBMC#24 Healthy control Male 51 95.4 96.1 No
PBMC#25 Healthy control Male 55 98.3 98.7 No
PBMC#26 Healthy control Male 32 87.6 89 No
PBMC#27 Healthy control Female 42 89.6 90.9 No
PBMC#28 Healthy control Female 36 92.9 93.8 No
PBMC#29 Healthy control Female 32 89.6 90.9 No
PBMC#30 Healthy control Female 48 87.3 88.7 No
PBMC#31 Healthy control Male 58 93.2 94.1 No
PBMC#32 Healthy control Male 55 94 94.8 No
PBMC#33 Healthy control Female 53 86.1 87.7 No
PBMC#34 Healthy control Female 52 85 86.7 No
PBMC#35 Healthy control Male 38 90.2 91.5 No